Image-guided core-needle or surgical biopsy for neuroblastoma diagnosis in children: A systematic review and meta-analysis from the International Society of Pediatric Surgical Oncology (IPSO).
image-guided biopsy
interventional radiology
neuroblastoma
percutaneous biopsy
surgical biopsy
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
revised:
15
11
2023
received:
08
09
2023
accepted:
16
11
2023
medline:
28
11
2023
pubmed:
28
11
2023
entrez:
28
11
2023
Statut:
aheadofprint
Résumé
Image-guided core-needle biopsy (IGCNB) is a widely used and valuable clinical tool for tissue diagnosis of pediatric neuroblastoma. However, open surgical biopsy remains common practice even if children undergo more invasive and painful procedures. This review aims to determine the diagnostic accuracy and safety of IGCNBs in pediatric patients with neuroblastoma. We conducted a systematic review of peer-reviewed original articles published between 1980 and 2023, by searching "pediatric oncology," "biopsy," "interventional radiology," and "neuroblastoma." Exclusion criteria were patients older than 18 years, studies concerning non-neurogenic tumors, case reports, and language other than English. Both the systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. A total of 533 abstracts articles were analyzed. Of these, eight retrospective studies met inclusion criteria (490 infants, 270 surgical biopsies [SB], 220 image-guided biopsies). Tissue adequacy for primary diagnosis (SB: n = 265, 98%; IGCNB: n = 199, 90%; p = .1) and biological characterization (SB: n = 186, 95%; IGCNB: n = 109, 89%; p = .15) was similar with both biopsy techniques, while intraoperative transfusion rate (SB: n = 51, 22%; IGCNB: n = 12, 6%; p = .0002) and complications (%) (SB: n = 58, 21%; IGCNB: n = 14, 6%; p = .005) were higher with surgical biopsy. Length of stay was similar in both groups; however, no additional data about concurrent diagnostic or treatment procedures were available in the analyzed studies. IGCNB is a safe and effective strategic approach for diagnostic workup of NB and should be considered in preferance to SB wherever possible.
Sections du résumé
BACKGROUND
BACKGROUND
Image-guided core-needle biopsy (IGCNB) is a widely used and valuable clinical tool for tissue diagnosis of pediatric neuroblastoma. However, open surgical biopsy remains common practice even if children undergo more invasive and painful procedures. This review aims to determine the diagnostic accuracy and safety of IGCNBs in pediatric patients with neuroblastoma.
METHODS
METHODS
We conducted a systematic review of peer-reviewed original articles published between 1980 and 2023, by searching "pediatric oncology," "biopsy," "interventional radiology," and "neuroblastoma." Exclusion criteria were patients older than 18 years, studies concerning non-neurogenic tumors, case reports, and language other than English. Both the systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.
RESULTS
RESULTS
A total of 533 abstracts articles were analyzed. Of these, eight retrospective studies met inclusion criteria (490 infants, 270 surgical biopsies [SB], 220 image-guided biopsies). Tissue adequacy for primary diagnosis (SB: n = 265, 98%; IGCNB: n = 199, 90%; p = .1) and biological characterization (SB: n = 186, 95%; IGCNB: n = 109, 89%; p = .15) was similar with both biopsy techniques, while intraoperative transfusion rate (SB: n = 51, 22%; IGCNB: n = 12, 6%; p = .0002) and complications (%) (SB: n = 58, 21%; IGCNB: n = 14, 6%; p = .005) were higher with surgical biopsy. Length of stay was similar in both groups; however, no additional data about concurrent diagnostic or treatment procedures were available in the analyzed studies.
CONCLUSIONS
CONCLUSIONS
IGCNB is a safe and effective strategic approach for diagnostic workup of NB and should be considered in preferance to SB wherever possible.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e30789Subventions
Organisme : American Lebanese Syrian Associated Charities
Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202-2211.
Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009;27(2):289-297.
Hussain HK, Kingston JE, Domizio P, Norton AJ, Reznek RH. Imaging-guided core biopsy for the diagnosis of malignant tumors in pediatric patients. AJR Am J Roentgenol. 2001;176(1):43-47.
Garrett KM, Fuller CE, Santana VM, Shochat SJ, Hoffer FA. Percutaneous biopsy of pediatric solid tumors. Cancer. 2005;104(3):644-652.
Hoffer FA, Chung T, Diller L, Kozakewich H, Fletcher JA, Shamberger RC. Percutaneous biopsy for prognostic testing of neuroblastoma. Radiology. 1996;200(1):213-216.
Gupta A, Kumar A, Walters S, Chait P, Irwin MS, Gerstle JT. Analysis of needle versus open biopsy for the diagnosis of advanced stage pediatric neuroblastoma. Pediatr Blood Cancer. 2006;47(7):875-879.
Wells G, Shea BJ, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605.
Hassan SF, Mathur S, Magliaro TJ, et al. Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children. J Pediatr Surg. 2012;47(6):1261-1266.
Mullassery D, Sharma V, Salim A, et al. Open versus needle biopsy in diagnosing neuroblastoma. J Pediatr Surg. 2014;49(10):1505-1507.
Overman RE, Kartal TT, Cunningham AJ, et al. Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma. Pediatr Blood Cancer. 2020;67(5):e28153.
Mohamed H, Pastor MC, Langlois S, Cowan KN. Comparing safety and adequacy between surgical biopsy versus core needle biopsy in diagnosing neuroblastoma. J Pediatr Surg. 2022;57(5):866-870.
Avanzini S, Faticato MG, Crocoli A, et al. Comparative retrospective study on the modalities of biopsying peripheral neuroblastic tumors: a report from the Italian Pediatric Surgical Oncology Group (GICOP). Pediatr Blood Cancer. 2017;64(5):e26284.
Campagna G, Rosenfeld E, Foster J, et al. Evolving biopsy techniques for the diagnosis of neuroblastoma in children. J Pediatr Surg. 2018;53(11):2235-2239.
Irwin MS, Naranjo A, Zhang FF, et al. Revised Neuroblastoma risk classification system: a report from the Children's Oncology Group. J Clin Oncol. 2021;39(29):3229-3241.
Simon T, Hero B, Schulte JH, et al. 2017 GPOH guidelines for diagnosis and treatment of patients with neuroblastic tumors. Klin Padiatr. 2017;217(3):147-152.
Bansal D, Totadri S, Chinnaswamy G, et al. Management of neuroblastoma: ICMR consensus document. Indian J Pediatr. 2017;84(6):446-455.
Ambros PF, Ambros IM, SIOP Europe Neuroblastoma Pathology, Biology, and Bone Marrow Group. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol. 2001;37(6):492-504.
Paraboschi I, Bolognesi E, Giannettoni A, Avanzini S, Torre M, Martucciello G. The role of biopsy in the workup of patients with neuroblastoma: comparison of the incidence of surgical complications and the diagnostic reliability of diverse techniques. Children (Basel). 2021;8(6):500. doi:10.3390/children8060500
Hwang M, Piskunowicz M, Darge K. Advanced ultrasound techniques for pediatric imaging. Pediatrics. 2019;143(3):e20182609.
Smith EA, Grove JJ, Van Der Spek AFL, Jarboe MD. Magnetic-resonance-guided biopsy of focal liver lesions. Pediatr Radiol. 2017;47(6):750-754.
Samoyedny A, Srinivasan A, States L, et al. Image-guided biopsy for relapsed neuroblastoma: focus on safety, adequacy for genetic sequencing, and correlation of tumor cell percent with quantitative lesion MIBG uptake. JCO Precis Oncol. 2021;5:PO2000171.
Interiano RB, Loh AH, Hinkle N, et al. Safety and diagnostic accuracy of tumor biopsies in children with cancer. Cancer. 2015;121(7):1098-1107.
Brady SW, Liu Y, Ma X, et al. Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations. Nat Commun. 2020;11(1):5183.
Schleiermacher G, Michon J, Huon I, et al. Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification. Br J Cancer. 2007;97(2):238-246.
Peuchmaur M, d'Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer. 2003;98(10):2274-2281.
Durand P, Moreau-Gaudry A, Silvent AS, et al. Computer assisted electromagnetic navigation improves accuracy in computed tomography guided interventions: a prospective randomized clinical trial. PLoS One. 2017;12(3):e0173751. doi:10.1371/journal.pone.0173751
Naumann H, Pittaway A, Lynn AM, Vo NJ. CT-guided percutaneous lung biopsy under general anesthesia: a pediatric case series and literature review. Pediatr Anaesth. 2012;22:469-475.